10 Photos of Mel Schilling: The 'Married at First Sight' Judge Who Just Shared a Devastating Cancer Update
The reality TV dating coach says doctors have no further treatment options as she steps away from television to focus on family

Mel Schilling, a dating coach known for her role on the reality programme Married at First Sight, has revealed that her cancer has spread to her brain. The 54-year-old television personality said she does not know how long she has left after doctors informed her there are no further treatment options available.
Schilling first announced that she had been diagnosed with colon cancer in December 2023. The diagnosis came while she was continuing her work as a relationship expert on Married at First Sight, where, since joining the programme in 2016, she has been a regular figure offering guidance to couples taking part in the reality series.
In a recent message shared online, Schilling explained that the disease later spread beyond its original location. Doctors confirmed that the cancer had moved to her lungs and had now spread to the left side of her brain.
She wrote, 'Despite subsequent radiotherapy sessions, my oncology team have now told me there is nothing further they can do.'
Treatment While Filming Married At First Sight
After her diagnosis, Schilling continued to work while receiving treatment. She said she underwent 16 rounds of chemotherapy while still filming the programme, and the show continued production while she balanced professional responsibilities with ongoing medical care.
Schilling also said that doctors identified a possible new treatment option. She had been told she was eligible for a 'groundbreaking clinical trial specific to my gene type,' which was expected to begin this month. However, a sudden change in her health prevented that plan from moving forward.
The Symptoms That Changed Her Condition
Schilling explained that new symptoms appeared around Christmas. She said she began experiencing 'blinding headaches and numbness down my right side,' and these symptoms later revealed that the cancer had spread to her brain.
She described the impact the illness now has on everyday activities and wrote that 'simple tasks have become incredibly difficult,' reflecting how her physical condition has changed in recent months. Schilling also said she is uncertain about how much time she has left, saying, 'I honestly don't know how long I have left, but I do know I will fight to my last breath.'
Family Support During Treatment
Alongside the update, Schilling shared a photograph with her husband and daughter. She used the message to acknowledge the support she has received from her family while undergoing treatment. Their presence has been part of the public message she has shared during this period.
She also used the moment to encourage others to seek medical advice if something feels wrong. In her message, she urged people to get checked if 'something doesn't feel right.'
In recent weeks, Schilling also announced a change to her television commitments. She confirmed that she was stepping away from the Australian version of Married at First Sight, a decision that was made so she could focus on her family and health during treatment. Schilling has been part of the programme since 2016 where she first appeared on the Australian series before later joining the UK version, which airs on E4.
Following her update, Channel 4 released a statement acknowledging her role on the programme. The broadcaster said Schilling had become a valued member of the network and described her as both a colleague and a friend to many people involved with the show. The statement said her presence on the programme has been marked by 'wisdom, warmth, humour and kindness.' The channel also said viewers and staff involved with Married at First Sight respect and value her contribution.
As filming continues for the latest UK series, production has confirmed a temporary replacement. Married at First Sight Australia expert John Aiken will step in to cover the remainder of the current UK season.
© Copyright IBTimes 2025. All rights reserved.



















